Skip to main content

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Cancer Data Access System (CDAS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	LeeVan, Elyse, M.D., M.P.H. elyse.leevan@nih.gov 240-276-7314	5E110	Program Officer \| Early Detection
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Miller, Eric, Ph.D. eric.miller2@nih.gov 240-276-5336	5E212	Program Officer \| Early Detection
	Ong, Mary Jane maryjane.ong@nih.gov 240-858-3296	5E120	Nurse Consultant \| Early Detection
	Pinsky, Paul, Ph.D. paul.pinsky@nih.gov 240-276-7014	5E108	Chief \| Early Detection
	Saxena, Neeraj, Ph.D. neeraj.saxena@nih.gov 240-276-6302	5E218	Program Officer \| Early Detection
	Zhu, Claire, Ph.D. claire.zhu@nih.gov 240-276-7013	5E106	Program Officer \| Early Detection

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Hayes, Richard Bernard	New York University School Of Medicine United States	The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer	5R01CA159036-09	Claire Zhu, Ph.D.
Hruska, Carrie B	Mayo Clinic Rochester United States	Density MATTERS Clinical Trial	5R01CA239200-05	Claire Zhu, Ph.D.
Hsu, Li	Fred Hutchinson Cancer Center United States	Statistical Methods for Precision Prevention	1R01CA297681-01	Claire Zhu, Ph.D.
James, Aimee S	Washington University United States	Administrative Supplement to Building equity in cancer screening through research: The Siteman Catchment CSRN Hub	3UG1CA286946-02S1	Elyse LeeVan, M.D., M.P.H.
Ji, Hanlee P	Stanford University United States	Single-molecule nanopore-based identification of methylome signatures in cfDNA for early colorectal cancer detection	5U01CA282212-02	Claire Zhu, Ph.D.
Kanetsky, Peter A	H. Lee Moffitt Cancer Ctr & Res Inst United States	A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers	5R01CA291735-02	Claire Zhu, Ph.D.
Kim, Michelle Kang	Cleveland Clinic Lerner Com-Cwru United States	Assessing feasibility of gastric cancer screening in the US	1R37CA300540-01	Claire Zhu, Ph.D.
Kooperberg, Charles L	Fred Hutchinson Cancer Center United States	Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN)	5UG1CA287013-02	Elyse LeeVan, M.D., M.P.H.
Krist, Alexander H	Virginia Commonwealth University United States	Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub)	3UG1CA287017-02S1	Elyse LeeVan, M.D., M.P.H.
Lee, Jeffrey Kuang Zou	Kaiser Foundation Research Institute United States	Vanguard Study Administrative Supplement	3UG1CA287011-02S1	Elyse LeeVan, M.D., M.P.H.
Livneh, Zvi	Weizmann Institute Of Science United States	Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort	5U01CA279001-03	Claire Zhu, Ph.D.
Lowry, Kathryn Paige	University Of Washington United States	Evaluation of Commercial Mammography-Based Artificial Intelligence Algorithms for Breast Cancer Risk Prediction in U.S. Screening Populations	5R37CA292399-02	Claire Zhu, Ph.D.
Nabavi, Sheida	University Of Connecticut Storrs United States	SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening	5R01CA297855-02	Claire Zhu, Ph.D.
Neslund-Dudas, Christine Marie	Henry Ford Health + Michigan State University Health Sciences United States	HFH-MSU CSRN ACCrual Enrollment and Screening Site	3UG1CA287007-02S1	Elyse LeeVan, M.D., M.P.H.
Ostrin, Edwin Justin	University Of Tx Md Anderson Can Ctr United States	Validation of blood-based biomarkers for risk assessment of lung cancer among individuals with no smoking history in the PLCO Cohort	1U01CA295902-01A1	Claire Zhu, Ph.D.